BKYI
BIO KEY INTERNATIONAL INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 12 BIO-key received a Nasdaq delisting notice after failing to maintain…
- R Jun 10 BIO-key received an additional Nasdaq delisting notice for failing t…
- R Aug 14 BIO-key reported Q2 2026 revenue of $1.9M (+13% YoY) and a net loss…
- R Aug 24 BIO-key International filed a DEFA14A supplement to its 2026 proxy s…
- X Sep 15 Short interest falls 39.1% to 6.6K
- X Sep 30 Short interest jumps 14917.0% to 995.3K
- R Oct 2 BIO-key International entered into four exchange agreements with Str…
- R Oct 9 BIO-key International filed an S-1 registration statement to registe…
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- EstimatesRISING
Current-quarter EPS estimate −$0.700 → −$0.350 over 90 days. 1 up, 0 down in 30 days.
- TrendUPTREND
10% above its 50-day average.
- SocialQUIET
Crowd 63° (warm) this week from 8 mentions: 3 bullish, 0 bearish. No setup call.
The Street
Price is below the lowest target. Median implies +602%.Targets as of Oct 26, 2026.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 30, 2026 | LACOUS MIRA K Chief Technology Officer | AWARD | $957.50 |
| Jun 30, 2026 | Sullivan James David Chief Legal Officer | AWARD | $957.50 |
| Jun 30, 2026 | DEPASQUALE MICHAEL W Chief Executive Officer | AWARD | $957.50 |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.35 | -$0.35–-$0.35 | +50.0% | $2.4M |
| Next Q | -$0.24 | -$0.24–-$0.24 | +40.0% | $2.7M |
| Current FY | -$1.62 | -$1.62–-$1.62 | +29.6% | $9.0M |
| Next FY | $0.22 | $0.22–$0.22 | — | $12.0M |
Short side
FINRA· Oct 15, 2026SecBot reports
16 filings · 5 press releases · 2 bullish · 8 bearish · 3 mixed · 3 neutral- BEARISH S-1Oct 9, 2026
BIO-key International filed an S-1 registration statement to register the resale of up to…
The stockholder vote on October 30, 2026 is the key catalyst. If approval is denied, the warrants remain unexercisable and the company loses a potential $5M capital infusion. Even if approved, the…
- NEUTRAL DEFA14AOct 6, 2026
BIO-key International filed additional definitive proxy soliciting materials (DEFA14A) to urge…
The outcome of Proposal 4 is uncertain and will be determined at the reconvened meeting on October 30. If approved, the warrant exercise could lead to dilution. Monitor stockholder voting patterns…
- NEUTRAL 8-KOct 6, 2026
BIO-key International filed an 8-K reporting that at its reconvened 2026 Annual Meeting on October…
The key overhang is Proposal 4 — if approved, the company can issue up to 1,236,668 shares upon exercise of warrants from the August 10 inducement, representing significant potential dilution (~114%…
- BEARISH 8-KOct 2, 2026
BIO-key International entered into four exchange agreements with Streeterville Capital to…
Monitor for immediate share resales by Streeterville given Rule 144 eligibility and the lender's track record. The full extinguishment of the secured note removes a debt overhang but replaces it…
All BKYI filing & press-release reports (21)
- S-1 reportOct 9, 2026
- DEFA14A reportOct 6, 2026
- 8-K reportOct 6, 2026
- 8-K reportOct 2, 2026
- PRESS-RELEASE reportSep 29, 2026
- DEFA14A reportAug 24, 2026
- 8-K reportAug 14, 2026
- PRESS-RELEASE reportAug 13, 2026
- PRESS-RELEASE reportAug 10, 2026
- PRESS-RELEASE reportJul 28, 2026
- 8-K reportJul 9, 2026
- 8-K reportJul 7, 2026
- 8-K reportJun 10, 2026
- 8-K reportMay 18, 2026
- PRESS-RELEASE reportMay 18, 2026
- 8-K reportMay 12, 2026
- 8-K reportApr 29, 2026
- 8-K reportMar 31, 2026
- 8-K reportApr 20, 2026
- PRESS-RELEASE reportMar 31, 2026
- PRESS-RELEASE reportMar 12, 2026